NeoGenomics launches blood-based cancer test PanTracer LBx

Go back to NeoGenomics launches blood-based cancer test PanTracer LBx
NEOGENOMICS (NASDAQ: NEO) Delayed: 18.64 --0 (-0%)
Previous Close $18.64    52 Week High $9.54 
Open $18.64    52 Week Low $5.49 
Day High $18.64    P/E 466.00 
Day Low $18.64    EPS $0.04 
Volume 869